Avid Bioservices
(NASDAQ:CDMO)
$7.97
-0.65[-7.54%]
At close: May 29
$7.97
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$16.00
Lowest Price Target1
$8.00
Consensus Price Target1
$10.00

Avid Bioservices Stock (NASDAQ:CDMO), Analyst Ratings, Price Targets, Predictions

Avid Bioservices Inc has a consensus price target of $10, established from looking at the 22 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Stephens & Co., and RBC Capital on April 30, 2024, March 11, 2024, and March 7, 2024. With an average price target of $9 between RBC Capital, Stephens & Co., and RBC Capital, there's an implied 12.92% upside for Avid Bioservices Inc from these 3 analyst ratings.

Analyst Trend
3
Dec 23
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Stephens & Co.
Craig-Hallum
Keybanc
William Blair

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Avid Bioservices

Buy NowGet Alert
04/30/2024Buy Now0.38%RBC Capital
Sean Dodge
$7 → $8MaintainsOutperformGet Alert
03/11/2024Buy Now50.56%Stephens & Co.
Jacob Johnson
$15 → $12MaintainsOverweightGet Alert
03/07/2024Buy Now-12.17%RBC Capital
Sean Dodge
→ $7ReiteratesOutperform → OutperformGet Alert
12/08/2023Buy Now-12.17%RBC Capital
Sean Dodge
$15 → $7MaintainsOutperformGet Alert
12/08/2023Buy Now100.75%Craig-Hallum
Matt Hewitt
$22 → $16MaintainsBuyGet Alert
12/08/2023Buy Now75.66%Keybanc
Paul Knight
$20 → $14MaintainsOverweightGet Alert
09/28/2023Buy NowWilliam Blair
Max Smock
Initiates → Market PerformGet Alert
09/08/2023Buy Now88.21%RBC Capital
Sean Dodge
$17 → $15MaintainsOutperformGet Alert
06/22/2023Buy Now113.3%RBC Capital
Sean Dodge
$20 → $17MaintainsOutperformGet Alert
06/22/2023Buy Now150.94%Stephens & Co.
Jacob Johnson
→ $24ReiteratesOverweight → OverweightGet Alert
03/14/2023Buy Now176.04%Stephens & Co.
Jacob Johnson
→ $22Reiterates → OverweightGet Alert
03/14/2023Buy Now150.94%RBC Capital
Sean Dodge
→ $20Reiterates → OutperformGet Alert
03/14/2023Buy Now150.94%Keybanc
Paul Knight
→ $20UpgradeSector Weight → OverweightGet Alert
12/07/2022Buy Now150.94%RBC Capital
Sean Dodge
$22 → $20MaintainsOutperformGet Alert
06/30/2022Buy Now176.04%RBC Capital
Sean Dodge
$32 → $22MaintainsOutperformGet Alert
03/09/2022Buy Now251.32%Stephens & Co.
Jacob Johnson
$31 → $28MaintainsOverweightGet Alert
12/08/2021Buy Now339.15%Craig-Hallum
Matt Hewitt
MaintainsBuyGet Alert
12/08/2021Buy Now301.51%RBC Capital
Sean Dodge
MaintainsOutperformGet Alert
12/08/2021Buy NowKeybanc
Paul Knight
DowngradeOverweight → Sector WeightGet Alert
06/30/2021Buy Now263.86%Craig-Hallum
Matt Hewitt
MaintainsBuyGet Alert
06/30/2021Buy Now238.77%RBC Capital
Sean Dodge
MaintainsOutperformGet Alert
06/30/2021Buy Now251.32%Keybanc
Paul Knight
MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Avid Bioservices (CDMO)?

A

The latest price target for Avid Bioservices (NASDAQ: CDMO) was reported by RBC Capital on April 30, 2024. The analyst firm set a price target for $8.00 expecting CDMO to rise to within 12 months (a possible 0.38% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Avid Bioservices (CDMO)?

A

The latest analyst rating for Avid Bioservices (NASDAQ: CDMO) was provided by RBC Capital, and Avid Bioservices maintained their outperform rating.

Q

When was the last upgrade for Avid Bioservices (CDMO)?

A

The last upgrade for Avid Bioservices Inc happened on March 14, 2023 when Keybanc raised their price target to $20. Keybanc previously had a sector weight for Avid Bioservices Inc.

Q

When was the last downgrade for Avid Bioservices (CDMO)?

A

The last downgrade for Avid Bioservices Inc happened on December 8, 2021 when Keybanc changed their price target from N/A to N/A for Avid Bioservices Inc.

Q

When is the next analyst rating going to be posted or updated for Avid Bioservices (CDMO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avid Bioservices, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avid Bioservices was filed on April 30, 2024 so you should expect the next rating to be made available sometime around April 30, 2025.

Q

Is the Analyst Rating Avid Bioservices (CDMO) correct?

A

While ratings are subjective and will change, the latest Avid Bioservices (CDMO) rating was a maintained with a price target of $7.00 to $8.00. The current price Avid Bioservices (CDMO) is trading at is $7.97, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch